STTK Shattuck Labs Inc

USD 10.86 0.38 3.625954
Icon

Shattuck Labs Inc (STTK) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 10.86

+0.38 (+3.63)%

USD 0.45B

0.20M

USD 16.00(+47.33%)

USD 9.30 (-14.36%)

Icon

STTK

Shattuck Labs Inc (USD)
COMMON STOCK | NSD
USD 10.86
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.45B

USD 9.30 (-14.36%)

USD 10.86

Shattuck Labs Inc (STTK) Stock Forecast

Show ratings and price targets of :
USD 16.00
(+47.33%)

Based on the Shattuck Labs Inc stock forecast from 2 analysts, the average analyst target price for Shattuck Labs Inc is USD 16.00 over the next 12 months. Shattuck Labs Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Shattuck Labs Inc is Very Bearish, which is based on 0 positive signals and 8 negative signals. At the last closing, Shattuck Labs Inc’s stock price was USD 10.86. Shattuck Labs Inc’s stock price has changed by +9.70% over the past week, +22.16% over the past month and +252.60% over the last year.

No recent analyst target price found for Shattuck Labs Inc
No recent average analyst rating found for Shattuck Labs Inc

Company Overview Shattuck Labs Inc

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopia...Read More

500 West 5th Street, Austin, TX, United States, 78701

75

December

USD

USA

Adjusted Closing Price for Shattuck Labs Inc (STTK)

Loading...

Unadjusted Closing Price for Shattuck Labs Inc (STTK)

Loading...

Share Trading Volume for Shattuck Labs Inc Shares

Loading...

Compare Performance of Shattuck Labs Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for STTK

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Shattuck Labs Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc +9.33 (+2.38%) USD102.73B 28.66 20.00

ETFs Containing STTK

Symbol Name STTK's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Shattuck Labs Inc (STTK) Stock

Based on ratings from 2 analysts Shattuck Labs Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 4 buy, sell and hold ratings.

Unfortunately we do not have enough data on STTK's stock to indicate if its a good dividend stock.

Based on targets from 2 analysts, the average taret price for STTK is USD 16.00 over the next 12 months. The maximum analyst target price is USD 28 while the minimum anlayst target price is USD 12.

Unfortunately we do not have enough data on STTK's stock to indicate if its overvalued.

The last closing price of STTK's stock was USD 10.86.

The most recent market capitalization for STTK is USD 0.45B.

Based on targets from 2 analysts, the average taret price for STTK is projected at USD 16.00 over the next 12 months. This means that STTK's stock price may go up by +47.33% over the next 12 months.

We can't find any ETFs which contains Shattuck Labs Inc's stock.

As per our most recent records Shattuck Labs Inc has 75 Employees.

Shattuck Labs Inc's registered address is 500 West 5th Street, Austin, TX, United States, 78701. You can get more information about it from Shattuck Labs Inc's website at https://www.shattucklabs.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...